Caas Capital Management LP Codex Dna, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.31 - $11.96 $220,850 - $418,600
-35,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$17.76 - $22.0 $621,600 - $770,000
35,000 New
35,000 $770,000

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0
View Full List

About Codex DNA, Inc.

DNAY Quotes by TradingView
  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email